Cambria Gold Mines management says Q2 2026 loss narrows on absence of prior-year C$324.4 million impairment charge
Reuters2026/08/29 04:28- Management commentary for Q2 2026 reported a net loss of CAD 2.96 million versus CAD 325.23 million a year earlier.
- Improvement mainly reflected no mineral property impairment charge versus CAD 324.4 million in the prior-year quarter.
- Fair-value losses on financial instruments fell by CAD 23.04 million, described as driven by lower share price and metal prices.
- Mine site related expenses rose to CAD 6.64 million as costs no longer met capitalization criteria.
- Share-based compensation increased to CAD 7.38 million, tied to grants to new directors and officers; unrealized FX loss rose by CAD 8 million.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Hyperliquid’s $249B volume lead – Can HYPE survive the crowd it created?
Cambria Gold Mines FY26 Q2 net loss narrows to CAD 2.96 million
TRUMP rises nearly 8% in 24 hours, market capitalization reaches $2.037 billions
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.
Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.
Crypto prices
More
